The results are in: $8.4M total (before costs) across its $5M placement and $3.4M entitlement offer.
Only ~$3.4M of the $10.8M offer was taken up (~31%). That’s low. i think it reflects fatigue from retail holders or just lack of confidence in near-term execution. For a company pushing into Phase 3, you'd expect stronger support.
That gives Recce a runway of ~9–10 months, potentially into Feb/March 2026,
✅ Launched a A$3.4M entitlement offer Placement + Entitlement = 6.8months
✅ A$10M R&D advance = 21.0months
✅ A$8.5M R&D rebate + R&D advance (expected Q4 2025).= 34.2months
that R&D is a life saver
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
-0.020(5.97%) |
Mkt cap ! $90.83M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 31.0¢ | $52.38K | 164.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7002 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 15624 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |